Gilson R J, Hawkins A E, Beecham M R, Ross E, Waite J, Briggs M, McNally T, Kelly G E, Tedder R S, Weller I V
Department of Sexually transmitted Diseases, University College London Medical School, UK.
AIDS. 1997 Apr;11(5):597-606. doi: 10.1097/00002030-199705000-00007.
Hepatitis B virus (HBV) and HIV infections share risk-factors; therefore coinfection is common. Interactions have been reported but controlled studies have been limited. Our objective was to study the effect of HIV infection on the natural history of chronic HBV infection and the reverse effect of the HBV carrier state on HIV infection.
Prospective observational cohort study.
Open-access outpatient HIV/genitourinary medicine clinic at a Central London hospital.
Total of 152 untreated homosexual male HBV carriers and 212 HBV surface antigen-negative controls (41.4 and 70.3% HIV-seropositive, respectively).
The rate of loss of serum HBV e antigen (HBeAg) and its reappearance in HIV-infected and HIV-uninfected HBV carriers; serum HBV DNA levels measured by dot-blot hybridization assay), HBV DNA polymerase activity and liver transaminase activities, the progression of HIV infection to symptomatic disease or AIDS in HIV-infected compared with HBV-HIV coinfected patients.
In HIV-infected HBV carriers, serum HBV DNA polymerase activity was higher, alanine aminotransferase was lower and loss of serum HBeAg (mean follow-up, 2.8 years) occurred at a lower rate when compared with HIV-uninfected HBV carriers (estimated relative hazard, 0.39; 95% confidence interval, 0.161-0.942) Concomitant chronic HBV infection had no detectable effect on the rate of progression of HIV disease after correction for lead-time bias.
This study strengthens the evidence for a significant effect of HIV infection on the natural history of chronic HBV infection, which by prolonging the period of infectivity could have an important impact on the epidemiology of HBV infection in regions, or patient groups, with high HIV seroprevalence. There was no evidence of an important effect of HBV carriage on HIV disease progression.
乙型肝炎病毒(HBV)感染与HIV感染有共同的危险因素,因此合并感染很常见。虽然已有关于两者相互作用的报道,但对照研究有限。我们的目的是研究HIV感染对慢性HBV感染自然史的影响,以及HBV携带状态对HIV感染的反向影响。
前瞻性观察队列研究。
伦敦市中心一家医院的开放式门诊HIV/泌尿生殖医学诊所。
共152名未经治疗的同性恋男性HBV携带者和212名HBV表面抗原阴性对照者(分别有41.4%和70.3%为HIV血清学阳性)。
HIV感染和未感染的HBV携带者血清中乙肝e抗原(HBeAg)消失率及其再次出现的情况;通过斑点杂交法检测的血清HBV DNA水平、HBV DNA聚合酶活性和肝转氨酶活性;与HBV-HIV合并感染患者相比,HIV感染患者发展为症状性疾病或艾滋病的进展情况。
与未感染HIV的HBV携带者相比,感染HIV的HBV携带者血清HBV DNA聚合酶活性更高,丙氨酸转氨酶更低,血清HBeAg消失率更低(平均随访2.8年)(估计相对风险为0.39;95%置信区间为0.161 - 0.942)。校正提前期偏倚后,慢性HBV合并感染对HIV疾病进展率没有可检测到的影响。
本研究进一步证明了HIV感染对慢性HBV感染自然史有显著影响,这通过延长传染性期可能对HIV血清流行率高的地区或患者群体的HBV感染流行病学产生重要影响。没有证据表明HBV携带对HIV疾病进展有重要影响。